Vericel Corporation
Vericel Corporation, a leading player in the regenerative medicine industry, is headquartered in the United States. Founded in 1989, the company has made significant strides in developing innovative cell-based therapies, particularly for patients with severe skin injuries and cartilage damage. Vericel's core products, including Epicel® and MACI®, are distinguished by their ability to harness the body’s own cells to promote healing, setting them apart in the competitive landscape of advanced therapeutics. With a strong presence in the US and expanding operations in key international markets, Vericel has established itself as a pioneer in the field. The company’s commitment to research and development has led to notable achievements, including FDA approvals that underscore its market position. Vericel continues to drive advancements in regenerative medicine, aiming to improve patient outcomes and redefine treatment paradigms.
DitchCarbon Score
How does Vericel Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vericel Corporation's score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Vericel Corporation's reported carbon emissions
Vericel Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, as indicated by the absence of specific emissions figures. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. As of now, Vericel Corporation does not inherit emissions data from any parent company, nor does it have any specific commitments to the Science Based Targets initiative (SBTi) or other climate-related frameworks. This lack of data and commitments suggests that Vericel may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is increasingly important for companies to establish clear emissions reduction targets and transparent reporting practices to align with global climate goals. Without specific emissions data or commitments, Vericel Corporation's climate impact remains unclear.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vericel Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
